Related Experiment Video
Updated: Jul 4, 2026

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay
Published on: December 26, 2019
Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix
1Division of Hematology-Oncology, Weill Medical College of Cornell University, Ithaca, NY 10021, USA.
Abstract:
Despite the discovery of thrombopoietin (TPO) and its contribution to megakaryocytopoiesis, the exact mechanisms and sites of platelet production are unknown. It has been shown that mature megakaryocytes (MKs) functionally express the stromal-derived factor 1 (SDF-1) receptor, CXCR4. SDF-1-induced migration of mature MKs through endothelial cell layers results in increased platelet production. Because the migration of polyploid MKs from the bone marrow microenvironment requires remodeling of the perivascular extracellular matrix, it was hypothesized that mature polyploid MKs may express matrix metalloproteinases (MMPs), facilitating their exit into the bone marrow extravascular space. In this report, it is demonstrated that SDF-1 induces the expression and release of gelatinase B (MMP-9) by purified mature polyploid human MKs and an adeno-CXCR4-infected megakaryocytic cell line. Neutralizing antibody to MMP-9, but not MMP-2, blocked SDF-1-induced migration of MKs through reconstituted basement membrane, suggesting that expression of MMP-9 is critical for MK migration. Incubation of mature MKs with a synthetic MMP inhibitor, 5-phenyl-1,10-phenanthrolene, resulted in the inhibition of platelet formation, suggesting that the expression of MMPs is not only critical for megakaryocyte migration but also for subsequent platelet release. Confirming these results, adeno-SDF-1 injection into normal mice resulted in increased platelet counts, a process that could be blocked by a synthetic MMP inhibitor. These results suggest mobilization of MKs involves sequential expression and activation of chemokine receptors such as CXCR4, MMP-9, followed by transendothelial migration. MMP inhibitors may have potential use in the treatment of thrombotic and myeloproliferative disorders. (Blood. 2000;96:4152-4159)
Insights
Mature megakaryocytes (MKs) migrate and release platelets by expressing matrix metalloproteinase-9 (MMP-9), a process stimulated by stromal-derived factor 1 (SDF-1) and its receptor CXCR4. MMP inhibitors may treat blood disorders.
Area of Science:
- Hematology
- Cell Biology
- Molecular Biology
Background:
- Thrombopoietin (TPO) is known to influence megakaryocytopoiesis, but the precise mechanisms and locations of platelet production remain unclear.
- Mature megakaryocytes (MKs) express the stromal-derived factor 1 (SDF-1) receptor, CXCR4, and SDF-1 induces their migration through endothelial cells, enhancing platelet production.
Purpose of the Study:
- To investigate the role of matrix metalloproteinases (MMPs) in megakaryocyte migration and platelet production.
- To determine if SDF-1 induces MMP expression in MKs and if MMPs are essential for MK migration and platelet release.
Main Methods:
- Purified mature human MKs and a megakaryocytic cell line were used to assess SDF-1-induced expression and release of MMP-9.
- Neutralizing antibodies against MMP-9 and MMP-2 were employed to evaluate their role in MK migration.
- Synthetic MMP inhibitors were used to assess their impact on platelet formation.
- Adeno-SDF-1 was injected into mice to confirm findings in vivo, with subsequent analysis of platelet counts and MMP inhibitor effects.
Main Results:
- SDF-1 stimulated the expression and release of gelatinase B (MMP-9) by mature MKs and a megakaryocytic cell line.
- Neutralization of MMP-9, but not MMP-2, inhibited SDF-1-induced MK migration through basement membrane.
- MMP inhibitors blocked both MK migration and subsequent platelet formation.
- In vivo administration of adeno-SDF-1 increased platelet counts in mice, an effect reversible by MMP inhibitors.
Conclusions:
- Megakaryocyte (MK) mobilization involves sequential expression and activation of CXCR4 and MMP-9, leading to transendothelial migration and platelet release.
- Matrix metalloproteinase-9 (MMP-9) plays a critical role in both MK migration and platelet formation.
- Matrix metalloproteinase (MMP) inhibitors show potential therapeutic value for thrombotic and myeloproliferative disorders.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Role of Matrix Metalloproteases in Degradation of ECM
A...
Intracellular Signaling Affects Focal Adhesions
Some...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

